Milk thistle (MT; Silybum marianum), a member of the Asteraceae family, is a therapeutic herb with a 2,000-year history of use. MT fruits contain a mixture of flavonolignans collectively known as silymarin, being silybin (also named silibinin) the main component. This article reviews the chemistry of MT, the pharmacokinetics and bioavailability, the pharmacologically relevant actions for liver diseases (e.g., anti-inflammatory, immunomodulating, antifibrotic, antioxidant, and liver-regenerating properties) as well as the clinical potential in patients with alcoholic liver disease, nonalcoholic fatty liver disease, viral hepatitis, drug-induced liver injury, and mushroom poisoning. Overall, literature data suggest that, despite encouraging preclinical data, further well-designed randomized clinical trials are needed to fully substantiate the real value of MT preparations in liver diseases.

Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases / Abenavoli, L.; Izzo, A. A.; Milić, N.; Cicala, C.; Santini, A.; Capasso, Raffaele.. - In: PHYTOTHERAPY RESEARCH. - ISSN 0951-418X. - 32:11(2018), pp. 2202-2213. [10.1002/ptr.6171]

Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases

Izzo A. A.;Cicala C.;Santini A.;Capasso Raffaele.
Ultimo
2018

Abstract

Milk thistle (MT; Silybum marianum), a member of the Asteraceae family, is a therapeutic herb with a 2,000-year history of use. MT fruits contain a mixture of flavonolignans collectively known as silymarin, being silybin (also named silibinin) the main component. This article reviews the chemistry of MT, the pharmacokinetics and bioavailability, the pharmacologically relevant actions for liver diseases (e.g., anti-inflammatory, immunomodulating, antifibrotic, antioxidant, and liver-regenerating properties) as well as the clinical potential in patients with alcoholic liver disease, nonalcoholic fatty liver disease, viral hepatitis, drug-induced liver injury, and mushroom poisoning. Overall, literature data suggest that, despite encouraging preclinical data, further well-designed randomized clinical trials are needed to fully substantiate the real value of MT preparations in liver diseases.
2018
Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases / Abenavoli, L.; Izzo, A. A.; Milić, N.; Cicala, C.; Santini, A.; Capasso, Raffaele.. - In: PHYTOTHERAPY RESEARCH. - ISSN 0951-418X. - 32:11(2018), pp. 2202-2213. [10.1002/ptr.6171]
File in questo prodotto:
File Dimensione Formato  
Abenavoli_et_al-2018-Phytotherapy_Research.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: Accesso privato/ristretto
Dimensione 406.31 kB
Formato Adobe PDF
406.31 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/724525
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 269
  • ???jsp.display-item.citation.isi??? 232
social impact